Shigella impairs human T lymphocyte responsiveness by hijacking actin cytoskeleton dynamics and T cell receptor vesicular trafficking
Strategies employed by pathogenic enteric bacteria, such as Shigella, to subvert the host adaptive immunity are not well defined. Impairment of T lymphocyte chemotaxis by blockage of polarised edge formation has been reported upon Shigella infection. However, the functional impact of Shigella on T l...
Saved in:
Published in | Cellular microbiology Vol. 22; no. 5; pp. e13166 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Inc
01.05.2020
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 1462-5814 1462-5822 1462-5822 |
DOI | 10.1111/cmi.13166 |
Cover
Summary: | Strategies employed by pathogenic enteric bacteria, such as Shigella, to subvert the host adaptive immunity are not well defined. Impairment of T lymphocyte chemotaxis by blockage of polarised edge formation has been reported upon Shigella infection. However, the functional impact of Shigella on T lymphocytes remains to be determined. Here, we show that Shigella modulates CD4+ T cell F‐actin dynamics and increases cell cortical stiffness. The scanning ability of T lymphocytes when encountering antigen‐presenting cells (APC) is subsequently impaired resulting in decreased cell–cell contacts (or conjugates) between the two cell types, as compared with non‐infected T cells. In addition, the few conjugates established between the invaded T cells and APCs display no polarised delivery and accumulation of the T cell receptor to the contact zone characterising canonical immunological synapses. This is most likely due to the targeting of intracellular vesicular trafficking by the bacterial type III secretion system (T3SS) effectors IpaJ and VirA. The collective impact of these cellular reshapings by Shigella eventually results in T cell activation dampening. Altogether, these results highlight the combined action of T3SS effectors leading to T cell defects upon Shigella infection. |
---|---|
Bibliography: | Funding information Agency of Science, Technology and Research (A*STAR), Singapore; Ecole polytechnique; INSIS‐CNRS Ingénierie translationnelle 2017; LabeX LaSIPS (ANR‐10‐LABX‐0040‐LaSIPS), Grant/Award Number: ANR‐10‐LABX‐0040‐LaSIPS; Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; the European Research Council, Grant/Award Numbers: 232798, 339579; the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence “Integrative Biology of Emerging Infectious Diseases”, Grant/Award Number: ANR‐10‐LABX‐62‐IBEID; the French Medical Research Foundation, Grant/Award Numbers: FDT20170437005, SPF20121226366; the French National Research Agency under the “Investissements d'avenir” program (ANR‐11‐IDEX‐0003‐02) ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC7187243 Funding information Agency of Science, Technology and Research (A*STAR), Singapore; Ecole polytechnique; INSIS‐CNRS Ingénierie translationnelle 2017; LabeX LaSIPS (ANR‐10‐LABX‐0040‐LaSIPS), Grant/Award Number: ANR‐10‐LABX‐0040‐LaSIPS; Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; the European Research Council, Grant/Award Numbers: 232798, 339579; the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence “Integrative Biology of Emerging Infectious Diseases”, Grant/Award Number: ANR‐10‐LABX‐62‐IBEID; the French Medical Research Foundation, Grant/Award Numbers: FDT20170437005, SPF20121226366; the French National Research Agency under the “Investissements d'avenir” program (ANR‐11‐IDEX‐0003‐02) |
ISSN: | 1462-5814 1462-5822 1462-5822 |
DOI: | 10.1111/cmi.13166 |